Approximately 48,000 deaths in the UK occur from sepsis every year
News
Stroke experts to test emerging nerve stimulation treatment
New stroke therapy delivers electrical pulses to the brain
Serac to present data from DETECT study
Company will present vital findings at SRI annual meeting
UCB announces MHRA approval for UCB’s Zilbrysq
Green light concerns generalised myasthenia gravis therapy
Synendos receives EMA nod for brain therapy
Company is focused on endocannabinoid system treatments
StemSight and ERS Genomics focus on collaboration
License agreement concerns development of cell therapies for corneal blindness
Poolbeg’s cytokine release syndrome drug shows potential
Data supports Poolbeg’s strategic expansion of POLB 001
Disco tunes into new cancer drug targets
EUR 20m to identify new targets and develop first in class drugs
Aston University receives £10m for membrane institute
Aston University to create the Aston Institute for Membrane Excellence
CellVoyant secures £7.6 million AI stem cell boost
CellVoyant’s platform combines AI with live cell imaging
Kanabo and City Dock Pharmacy team up
Companies collaborate to launch walk-in pain clinic
Cambridge researchers begin new trial for oesophageal cancer screening
If successful, the new test could see routine screening introduced in the NHS
Study reveals antibiotic use is not the only driver of antibiotic resistance
Researchers compared 20 years of antibiotic use on E. coli in the UK and Norway
New data reveals out-of-hospital cardiac survival results remain low in England
In 2022, around 8% of patients survived 30 days after a cardiac arrest
Inhalable sensor to make lung cancer screening more accessible worldwide
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser
